Epidemiology of heart failure and left ventricular systolic dysfunction after acute myocardial infarction: Prevalence, clinical characteristics, and prognostic importance

被引:153
作者
Weir, Robin A. P.
McMurray, John J. V. [1 ]
Velazquez, Eric J.
机构
[1] Univ Glasgow, Western Infirm, Dept Cardiol, Glasgow G11 6NT, Lanark, Scotland
[2] Duke Univ, Med Ctr, Dept Med, Div Cardiol, Durham, NC 27710 USA
[3] Duke Univ, Clin Res Inst, Durham, NC USA
关键词
D O I
10.1016/j.amjcard.2006.03.005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The development of heart failure and/or left ventricular systolic dysfunction (LVSD) in the setting of acute myocardial infarction (AMI) results in significant risk far above that of AMI, independently. In patients admitted to the hospital for AMI, concomitant heart failure and/or LVSD on hospital admission or development of either or both of these conditions during admission are among the strongest predictors of inhospital death and are associated with significant increases in inhospital, 30-day, and long-term mortality and rehospitalization rates. Given the high risks in this population, aggressive treatment, comprising early initiation and sustained use of evidence-based treatments, is essential for improving prognosis.
引用
收藏
页码:13F / 25F
页数:13
相关论文
共 51 条
[1]   Clinical predictors of heart failure in patients with first acute myocardial infarction [J].
Ali, AS ;
Rybicki, BA ;
Alam, M ;
Wulbrecht, N ;
Richer-Cornish, K ;
Khaja, F ;
Sabbah, HN ;
Goldstein, S .
AMERICAN HEART JOURNAL, 1999, 138 (06) :1133-1139
[2]  
*AM HEART AS, 2005, HEART DIS STROK STAT
[3]  
Anavekar NS, 2004, NEW ENGL J MED, V351, P1285, DOI 10.1056/NEJMoa041365
[4]   Early administration of intravenous magnesium to high-risk patients with acute myocardial infarction in the Magnesium in Coronaries (MAGIC) Trial: a randomised controlled trial [J].
Antman, E ;
Cooper, H ;
Domanski, M ;
Feinstein, S ;
Gersh, B ;
Gibler, WB ;
Haigney, M ;
Hochman, J ;
McKinlay, S ;
Norman, J ;
Opie, L ;
Rogers, W ;
Rosenberg, Y ;
Woods, K ;
Mills, P ;
Rosenberg, Y ;
Assmann, S ;
Woods, K ;
Nannicelli, J ;
Scott, J ;
Oakleaf, K ;
Singh, S ;
Davis, B ;
Hallstrom, A ;
Levine, R ;
Robertson, R ;
Norman, J ;
Gretton, V ;
Scott, K ;
Dolan, S ;
Brown, M ;
Ewart, A ;
Hendriks, R ;
Jeffrey, I ;
Newman, R ;
Quinn, W ;
Rankin, J ;
Russell, A ;
Singh, B ;
Waites, J ;
Ziffer, R ;
Smetana, R ;
Col, J ;
Bruno, P ;
Evrard, P ;
Massart, PE ;
Vrabevski, M ;
Andreev, N ;
Benov, H ;
Boichev, B .
LANCET, 2002, 360 (9341) :1189-1196
[5]  
BALL SG, 1993, LANCET, V342, P821
[6]   Heart failure and death after myocardial infarction in the community - The emerging role of mitral regurgitation [J].
Bursi, F ;
Enriquez-Sarano, M ;
Nkomo, VT ;
Jacobsen, SJ ;
Weston, SA ;
Meverden, RA ;
Roger, VL .
CIRCULATION, 2005, 111 (03) :295-301
[7]   Management of acute myocardial infarction in intensive care units in 1995: A nationwide French survey of practice and early hospital results [J].
Danchin, N ;
Vaur, L ;
Genes, N ;
Renault, M ;
Ferrieres, J ;
Etienne, S ;
Cambou, JP .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 30 (07) :1598-1605
[8]   Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial [J].
Dargie, HJ ;
Colucci, Y ;
Ford, I ;
Sendon, JLL ;
Remme, W ;
Sharpe, N ;
Blank, A ;
Holcslaw, TL .
LANCET, 2001, 357 (9266) :1385-1390
[9]   CHARACTERISTICS AND PROGNOSIS OF PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION IN RELATION TO OCCURRENCE OF CONGESTIVE-HEART-FAILURE [J].
EMANUELSSON, H ;
KARLSON, BW ;
HERLITZ, J .
EUROPEAN HEART JOURNAL, 1994, 15 (06) :761-768
[10]   A comparison of the national registry of myocardial infarction 2 with the Cooperative Cardiovascular Project [J].
Every, NR ;
Frederick, PD ;
Robinson, M ;
Sugarman, J ;
Bowlby, L ;
Barron, HV .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 33 (07) :1886-1894